Clinical Trial Update: N-Acetylcysteine for Youth Cannabis Use Disorder [Phase 2, Phase 3]

View source ↗

Summary

Phase 2 and Phase 3 clinical trials evaluating N-acetylcysteine for youth cannabis use disorder have completed, with results posted on 2024-12-17.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cannabis Use Disorder

Drugs mentioned

• N-acetylcysteine (N-acetylcysteine)

Snippet

Sponsor: Medical University of South Carolina | Conditions: Cannabis Use Disorder | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2024-12-17